PALYNZIQ Trademark

Trademark Overview


On Wednesday, July 5, 2017, a trademark application was filed for PALYNZIQ with the United States Patent and Trademark Office. The USPTO has given the PALYNZIQ trademark a serial number of 87516640. The federal status of this trademark filing is REGISTERED as of Tuesday, October 2, 2018. This trademark is owned by Biomarin Pharmaceutical Inc.. The PALYNZIQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of genetic diseases and disorders; Pharmaceutical preparations for use in enzyme therapy
palynziq

General Information


Serial Number87516640
Word MarkPALYNZIQ
Filing DateWednesday, July 5, 2017
Status700 - REGISTERED
Status DateTuesday, October 2, 2018
Registration Number5576853
Registration DateTuesday, October 2, 2018
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, November 7, 2017

Trademark Statements


Description of MarkThe mark consists of an upper-case of letter "P" and the lower-case letters of "alynziq".
Goods and ServicesPharmaceutical preparations for the treatment of genetic diseases and disorders; Pharmaceutical preparations for use in enzyme therapy
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 12, 2017
Primary Code005
First Use Anywhere DateMonday, July 2, 2018
First Use In Commerce DateMonday, July 2, 2018

Trademark Owner History


Party NameBiomarin Pharmaceutical Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNovato, CA 94949

Party NameBiomarin Pharmaceutical Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNovato, CA 94949

Party NameBiomarin Pharmaceutical Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNovato, CA 94949

Trademark Events


Event DateEvent Description
Saturday, July 8, 2017NEW APPLICATION ENTERED
Thursday, June 28, 2018SOU EXTENSION 1 FILED
Wednesday, July 12, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 28, 2017ASSIGNED TO EXAMINER
Thursday, September 28, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 18, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 7, 2017PUBLISHED FOR OPPOSITION
Tuesday, November 7, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 2, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, June 28, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 28, 2018SOU TEAS EXTENSION RECEIVED
Thursday, June 28, 2018SOU EXTENSION 1 GRANTED
Wednesday, December 9, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, June 30, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 23, 2018TEAS STATEMENT OF USE RECEIVED
Monday, July 23, 2018USE AMENDMENT FILED
Monday, August 20, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 21, 2018STATEMENT OF USE PROCESSING COMPLETE
Tuesday, August 28, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, August 29, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 2, 2018REGISTERED-PRINCIPAL REGISTER
Wednesday, December 9, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 9, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, December 9, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 30, 2024TEAS SECTION 8 & 15 RECEIVED
Monday, October 2, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED